605033 Stock Overview
Engages in the research and development, production, and sale of pesticide preparations. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥12.68 |
| 52 Week High | CN¥19.49 |
| 52 Week Low | CN¥9.73 |
| Beta | 0.49 |
| 11 Month Change | 3.59% |
| 3 Month Change | 16.97% |
| 1 Year Change | -32.84% |
| 33 Year Change | -18.82% |
| 5 Year Change | n/a |
| Change since IPO | -30.60% |
Recent News & Updates
Shareholder Returns
| 605033 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 3.0% | -0.9% | -2.1% |
| 1Y | -32.8% | -5.3% | 2.8% |
Return vs Industry: 605033 underperformed the CN Chemicals industry which returned -5.3% over the past year.
Return vs Market: 605033 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 605033 volatility | |
|---|---|
| 605033 Average Weekly Movement | 6.0% |
| Chemicals Industry Average Movement | 8.0% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 605033 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 605033's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 939 | Tong Zhang | www.meibang.cn |
Shaanxi Meibang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pesticide preparations. Its products include insecticides, fungicides, herbicides, plant growth regulators, fertilizers, and microbial fertilizers. The company is also engaged in the sales of agricultural machinery, fertilizers, and agricultural and sideline products, as well as offers technical consulting services.
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Fundamentals Summary
| 605033 fundamental statistics | |
|---|---|
| Market cap | CN¥1.71b |
| Earnings (TTM) | CN¥30.64m |
| Revenue (TTM) | CN¥768.17m |
55.9x
P/E Ratio2.2x
P/S RatioIs 605033 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 605033 income statement (TTM) | |
|---|---|
| Revenue | CN¥768.17m |
| Cost of Revenue | CN¥554.75m |
| Gross Profit | CN¥213.43m |
| Other Expenses | CN¥182.78m |
| Earnings | CN¥30.64m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 27.78% |
| Net Profit Margin | 3.99% |
| Debt/Equity Ratio | 6.4% |
How did 605033 perform over the long term?
See historical performance and comparison